| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression
|
Kathman, Steven J.
|
|
2008
|
63 |
3 |
p. 469-476
|
artikel
|
| 2 |
A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state
|
O’Bryant, C. L.
|
|
2008
|
63 |
3 |
p. 477-489
|
artikel
|
| 3 |
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients
|
Woodahl, Erica L.
|
|
2008
|
63 |
3 |
p. 391-401
|
artikel
|
| 4 |
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite
|
Hemmingsson, O.
|
|
2008
|
63 |
3 |
p. 491-499
|
artikel
|
| 5 |
Carbamazepine induces bioactivation of cyclophosphamide and thiotepa
|
Ekhart, Corine
|
|
2008
|
63 |
3 |
p. 543-547
|
artikel
|
| 6 |
Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
|
Okabayashi, Koji
|
|
2008
|
63 |
3 |
p. 501-507
|
artikel
|
| 7 |
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study
|
Feliu, Jaime
|
|
2008
|
63 |
3 |
p. 403-409
|
artikel
|
| 8 |
Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma
|
Kalender, Mehmet Emin
|
|
2008
|
63 |
3 |
p. 561
|
artikel
|
| 9 |
Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma
|
Kalender, Mehmet Emin
|
|
2008
|
63 |
3 |
p. 555-559
|
artikel
|
| 10 |
Effect of antacid on imatinib absorption
|
Sparano, Brian A.
|
|
2008
|
63 |
3 |
p. 525-528
|
artikel
|
| 11 |
Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
|
Shim, Ju Hyun
|
|
|
63 |
3 |
p. 459-467
|
artikel
|
| 12 |
Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
|
Shim, Ju Hyun
|
|
2008
|
63 |
3 |
p. 459-467
|
artikel
|
| 13 |
Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma
|
Younis, Islam R.
|
|
2008
|
63 |
3 |
p. 517-524
|
artikel
|
| 14 |
Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand
|
Gourdeau, Henriette
|
|
2008
|
63 |
3 |
p. 569
|
artikel
|
| 15 |
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine
|
Lemaire, Maryse
|
|
2008
|
63 |
3 |
p. 411-416
|
artikel
|
| 16 |
MDA-MB-435 cells are from melanoma, not from breast cancer
|
Lacroix, Marc
|
|
2008
|
63 |
3 |
p. 567
|
artikel
|
| 17 |
Pathologic complete response after palliative 3rd line chemotherapy with capecitabine alone in metastatic colorectal cancer
|
Cho, Hyeon Jin
|
|
2008
|
63 |
3 |
p. 549-553
|
artikel
|
| 18 |
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias
|
Marangon, Elena
|
|
2008
|
63 |
3 |
p. 563-566
|
artikel
|
| 19 |
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies
|
Fracasso, Paula M.
|
|
2008
|
63 |
3 |
p. 451-458
|
artikel
|
| 20 |
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine
|
Krishnamurthi, Smitha S.
|
|
2008
|
63 |
3 |
p. 441-450
|
artikel
|
| 21 |
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy
|
Awada, Ahmad
|
|
2008
|
63 |
3 |
p. 417-425
|
artikel
|
| 22 |
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
|
Zang, Dae Young
|
|
2008
|
63 |
3 |
p. 509-516
|
artikel
|
| 23 |
Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer
|
Kim, Yoon Jae
|
|
2008
|
63 |
3 |
p. 529-533
|
artikel
|
| 24 |
Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
|
Lee, Hyo Jin
|
|
2008
|
63 |
3 |
p. 427-432
|
artikel
|
| 25 |
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
|
Kim, Hee Man
|
|
2008
|
63 |
3 |
p. 535-541
|
artikel
|
| 26 |
Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis
|
Seo, Hee Yeon
|
|
2008
|
63 |
3 |
p. 433-439
|
artikel
|
| 27 |
Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas
|
Erlich, Rafael B.
|
|
2008
|
63 |
3 |
p. 381-389
|
artikel
|
Tijdschrift beschrijving